article thumbnail

What’s next for Container Closure Integrity Testing?

Pharmaceutical Technology

A vitally important assay used across various stages of drug development and manufacturing, container closure integrity testing (CCIT) involves evaluating packaging systems to determine their ability to protect the stability and sterility of pharmaceutical products. The evolution of CCIT. Many test methods have thus been developed.

article thumbnail

The rising importance of containment in small molecule drug development

Pharmaceutical Technology

On the other hand, the current trend is for fully closed systems that use negative pressure to keep particles contained inside isolators. Many companies are now prioritising investments in containment systems, GlobalData research shows. But containment is not only important at commercial-stage manufacturing.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A winning combination: The benefits of micronization and containment in a single installation

Pharmaceutical Technology

This, coupled with small pharma companies being unable to acquire or access containment capabilities in-house, means that the demand for innovative specialized small molecule capabilities remains high. Of those, only 935 (34%) small molecule API facilities offered some type of containment capabilities.

article thumbnail

Container Closure Integrity Testing (CCIT): How to get started with deterministic methods

Pharmaceutical Technology

With the new version of EU GMP Annex 1 coming into effect on 25 August this year, big changes to the way the pharmaceutical industry approaches container closure integrity testing (CCIT) are in motion. In addition, 100% testing is now required for fusion-sealed containers such as ampoules and IV bags.

article thumbnail

Just how bad is Facebook health information? Really bad

World of DTC Marketing

Experiences from current patients do provide some context but too often contain lousy advice. In my opinion, pharma companies should avoid Facebook at all costs. SUMMARY: The health information on Facebook is a danger to anyone who reads it. It was an excellent piece of investigative journalism.

Doctors 197
article thumbnail

The social media problem for healthcare

World of DTC Marketing

SUMMARY: The Facebook whistleblower lawsuit can be summed up in one sentence: Facebook prioritizes engagement above all else because it leads to more profits even if that engagement containing inflammatory information. A year ago, Facebook was making a hard charge to get the pharma business.

Branding 224
article thumbnail

So much for pharma earning trust back

World of DTC Marketing

Pfizer and Moderna have provided data from their large-scale Phase 3 trials only via news releases , which contained the highly promising news that both vaccines were 90 percent effective or more and have not presented any serious safety concerns. It seems that we were premature to think that pharma is earning trust back.